RadNet, Inc.
RDNTNasdaqCIK 790526HealthcareFiscal year ends Dec 31
Reports and events: 296 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2616:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-008094 |
| 2026-08-1416:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-006479 |
| 2026-08-1017:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-055338 |
| 2026-08-1006:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-006125 |
| 2026-06-1017:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-004716 |
| 2026-06-0421:08 ET | 8-K | 5.07 Shareholder vote results | 0001683168-26-004522 |
| 2026-06-0308:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-004475 |
| 2026-05-1116:40 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-033607 |
| 2026-05-1107:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-003624 |
| 2026-04-2017:15 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001683168-26-003086 |
| 2026-03-0217:17 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-013337 |
| 2026-03-0207:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-26-001385 |
| 2026-03-0207:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-001384 |
| 2026-01-3016:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-26-000636 |
| 2026-01-0916:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-26-000190 |
| 2025-12-0417:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-008900 |
| 2025-11-1016:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000790526-25-000008 |
| 2025-11-1008:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-008100 |
| 2025-10-2116:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-25-007694 |
| 2025-08-1116:37 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-039605 |
| 2025-08-1106:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-005844 |
| 2025-07-1716:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-005180 |
| 2025-06-1216:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-004440 |
| 2025-05-1216:09 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-024672 |
| 2025-05-1209:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-003385 |
| 2025-04-2806:19 ET | DEF 14A | Proxy statementPeriod 2025-06-10 | 0001683168-25-002862 |
| 2025-04-2806:07 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001683168-25-002860 |
| 2025-04-1516:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-25-002591 |
| 2025-03-0515:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-25-001349 |
| 2025-03-0317:00 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-009481 |
| 2024-11-2617:28 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001683168-24-008404 |
| 2024-11-1217:06 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-047285 |
| 2024-11-1216:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-007907 |
| 2024-10-1118:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-007058 |
| 2024-09-1216:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-24-006338 |
| 2024-08-0916:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-005428 |
| 2024-08-0916:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-036466 |
| 2024-06-1316:55 ET | 8-K | 5.07 Shareholder vote results | 0001683168-24-004201 |
| 2024-05-1318:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-003246 |
| 2024-05-1016:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-022619 |
| 2024-04-2616:05 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001683168-24-002737 |
| 2024-04-1817:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001683168-24-002513 |
| 2024-04-1106:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-002291 |
| 2024-04-0308:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-002073 |
| 2024-03-1216:18 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-001430 |
| 2024-03-0514:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-001310 |
| 2024-02-2916:57 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-008035 |
| 2024-01-0516:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001683168-24-000099 |
| 2023-11-1307:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-007874 |
| 2023-11-0917:22 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-038345 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:12 ET. Listed shows no prices and gives no investment advice.